Forcefield Therapeutics
PrivateLast Round
Seed
Apr 25, 2022
Total Funding Raised
$45.1M
Company Overview
Forcefield Therapeutics operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Seed round in April 2022.
Forcefield Therapeutics is a biotechnology company that develops therapeutics to protect heart function by arresting the loss of cardiomyocytes following myocardial infarction.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Forcefield Therapeutics Comparables
Compare Forcefield Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Infensa Bioscience | 84% | |
| SERCA Pharmaceuticals | 80% | |
| Heqet Therapeutics | 78% |
For institutional investors. Book with your work email.
Forcefield Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Forcefield Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Roche Venture Fund | Series A |
| Syncona | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Monthly visitors grew 68% MoM.
- Jun 20, 2024
$38.1M round led by Syncona.
For institutional investors. Book with your work email.
Forcefield Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Forcefield Therapeutics's valuation, stock price, and market status.
Is Forcefield Therapeutics a public or private company?
Forcefield Therapeutics is a private company.
What is the current stock price of Forcefield Therapeutics?
Forcefield Therapeutics is a private company, so its shares have no public market price. Caplight tracks Forcefield Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Forcefield Therapeutics worth (valuation)?
Valuation information for Forcefield Therapeutics is not publicly available.
Can I buy Forcefield Therapeutics stock?
Forcefield Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Forcefield Therapeutics's last funding round?
Forcefield Therapeutics's most recent funding round was Seed on April 25, 2022.
Who are the main investors in Forcefield Therapeutics?
Key investors in Forcefield Therapeutics include Syncona.
Will Forcefield Therapeutics IPO soon?
No public IPO plans have been announced for Forcefield Therapeutics.
How can I track Forcefield Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Forcefield Therapeutics's shares on secondary markets.